Springworks TherapeuticsSWTX
13F holders, Q4 2025 (December 31)2holders −1
0new positions
1sold out
$54.47avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Springworks Therapeutics Inc. (SWTX) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holders were DekaBank Deutsche Girozentrale ($2.2M) and Huntington National Bank ($47).
- Company
- Springworks Therapeutics Inc.
- CUSIP
- 85205L107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $4K |
All 13F filers, Q3 2025 → Q4 2025: 83 shares sold, net −83 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| DekaBank Deutsche Girozentrale | 0.00% | No change | 40,000 | $2.2M |
| Huntington National Bank | 0.00% | No change | 1 | $47 |
"% of holder's portfolio" is SWTX's weight in each manager's 13F, not the share of Springworks Therapeutics Inc. the manager owns.